BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26132144)

  • 1. Rigidity Emerges during Antibody Evolution in Three Distinct Antibody Systems: Evidence from QSFR Analysis of Fab Fragments.
    Li T; Tracka MB; Uddin S; Casas-Finet J; Jacobs DJ; Livesay DR
    PLoS Comput Biol; 2015 Jul; 11(7):e1004327. PubMed ID: 26132144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic stability and flexibility characteristics of antibody fragment complexes.
    Li T; Verma D; Tracka MB; Casas-Finet J; Livesay DR; Jacobs DJ
    Protein Pept Lett; 2014; 21(8):752-65. PubMed ID: 23855672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repertoire Analysis of Antibody CDR-H3 Loops Suggests Affinity Maturation Does Not Typically Result in Rigidification.
    Jeliazkov JR; Sljoka A; Kuroda D; Tsuchimura N; Katoh N; Tsumoto K; Gray JJ
    Front Immunol; 2018; 9():413. PubMed ID: 29545810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDR-H3 loop ensemble in solution - conformational selection upon antibody binding.
    Fernández-Quintero ML; Kraml J; Georges G; Liedl KR
    MAbs; 2019; 11(6):1077-1088. PubMed ID: 31148507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody evolution constrains conformational heterogeneity by tailoring protein dynamics.
    Zimmermann J; Oakman EL; Thorpe IF; Shi X; Abbyad P; Brooks CL; Boxer SG; Romesberg FE
    Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13722-7. PubMed ID: 16954202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
    Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
    Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conserved quantitative stability/flexibility relationships (QSFR) in an orthologous RNase H pair.
    Livesay DR; Jacobs DJ
    Proteins; 2006 Jan; 62(1):130-43. PubMed ID: 16287093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redistribution of flexibility in stabilizing antibody fragment mutants follows Le Châtelier's principle.
    Li T; Tracka MB; Uddin S; Casas-Finet J; Jacobs DJ; Livesay DR
    PLoS One; 2014; 9(3):e92870. PubMed ID: 24671209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-linking disulfide bonds govern solution structures of diabodies.
    Math BA; Waibl F; Lamp LM; Fernández-Quintero ML; Liedl KR
    Proteins; 2023 Sep; 91(9):1316-1328. PubMed ID: 37376973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding.
    Koenig P; Lee CV; Walters BT; Janakiraman V; Stinson J; Patapoff TW; Fuh G
    Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E486-E495. PubMed ID: 28057863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Design To Reduce Conformational Flexibility and Aggregation Rates of an Antibody Fab Fragment.
    Zhang C; Samad M; Yu H; Chakroun N; Hilton D; Dalby PA
    Mol Pharm; 2018 Aug; 15(8):3079-3092. PubMed ID: 29897777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unifying mechanical and thermodynamic descriptions across the thioredoxin protein family.
    Mottonen JM; Xu M; Jacobs DJ; Livesay DR
    Proteins; 2009 May; 75(3):610-27. PubMed ID: 19004018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating protein thermodynamics from the three-dimensional structure of the native state using network rigidity.
    Jacobs DJ; Dallakyan S
    Biophys J; 2005 Feb; 88(2):903-15. PubMed ID: 15542549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
    J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VL:VH domain rotations in engineered antibodies: crystal structures of the Fab fragments from two murine antitumor antibodies and their engineered human constructs.
    Banfield MJ; King DJ; Mountain A; Brady RL
    Proteins; 1997 Oct; 29(2):161-71. PubMed ID: 9329081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing recombinant antibody function in SPR immunosensing. The influence of antibody structural format and chip surface chemistry on assay sensitivity.
    Townsend S; Finlay WJ; Hearty S; O'Kennedy R
    Biosens Bioelectron; 2006 Aug; 22(2):268-74. PubMed ID: 16487701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABGEN: a knowledge-based automated approach for antibody structure modeling.
    Mandal C; Kingery BD; Anchin JM; Subramaniam S; Linthicum DS
    Nat Biotechnol; 1996 Mar; 14(3):323-8. PubMed ID: 9630894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
    Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
    J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody Structure.
    Stanfield RL; Wilson IA
    Microbiol Spectr; 2014 Apr; 2(2):. PubMed ID: 26105818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.